Literature DB >> 25440147

Distribution & diagnostic efficacy of cardiac markers CK-MB & LDH in pericardial fluid for postmortem diagnosis of ischemic heart disease.

Pankaj Suresh Ghormade1, Narendra Baluram Kumar2, Chaitanya Vidyadhar Tingne2, Ajay Narmadaprasad Keoliya2.   

Abstract

The aim of the present study is to evaluate the diagnostic efficacy of biochemical markers creatine kinase-MB (CK-MB) and LDH in pericardial fluid for postmortem diagnosis of ischemic heart disease (IHD). We studied 119 medico-legal autopsies selected during a period of 2 years. Subjects were assigned into diagnostic groups upon final cause of death as follows: (1) sudden cardiac death due to IHD's (n = 52), (2) violent asphyxia (n = 24); (3) polytraumatic deaths (n = 20); (4) natural deaths excluding cardiac causes (n = 23). Pericardial fluid samples were tested for estimating enzyme levels. Histological examination was performed with hematoxylin and eosin (H&amp;E) stain on myocardial tissue samples. We observed highest levels of CK-MB &amp; LDH in deaths due to IHD's. Kruskal-Wallis test revels significant differences in activities of CK-MB (P = 0.0001) and LDH (P = 0.0065) amongst all diagnostic groups. Mann-Whitney test showed highly significant (P < 0.0001) levels of CK-MB in group 1 as compared to other diagnostic groups. However, LDH levels were non-discriminatory (P = 0.0827) between cases of IHD's and cases of other natural deaths. CK-MB levels were statistically non-significant between cases divided as myocardial infarction (MI) and severe coronary artery disease in group 1, hence its role for postmortem detection of MI is somewhat limiting. However, sensitivity and negative predictive values of its cut off level obtained in cases of IHD's are nearly equal to diagnostic efficacy in clinical settings. Hence, it can be useful additional diagnostic tool for autopsy diagnosis of IHD's. Whereas, LDH is not useful for postmortem diagnosis in these cases.
Copyright © 2014 Elsevier Ltd and Faculty of Forensic and Legal Medicine. All rights reserved.

Entities:  

Keywords:  CK-MB; Ischemic heart disease; LDH; Myocardial infarction; Pericardial fluid

Mesh:

Substances:

Year:  2014        PMID: 25440147     DOI: 10.1016/j.jflm.2014.09.011

Source DB:  PubMed          Journal:  J Forensic Leg Med        ISSN: 1752-928X            Impact factor:   1.614


  3 in total

1.  Evaluation of rosmarinic acid against myocardial infarction in maternally separated rats.

Authors:  Himanshu Verma; Anindita Bhattacharjee; Naveen Shivavedi; Prasanta Kumar Nayak
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-07-25       Impact factor: 3.195

2.  Guanxin Danshen Formulation Protects against Myocardial Ischemia Reperfusion Injury-Induced Left Ventricular Remodeling by Upregulating Estrogen Receptor β.

Authors:  Xuehong Deng; Xiaoyan Xing; Guibo Sun; Xudong Xu; Haifeng Wu; Guang Li; Xiaobo Sun
Journal:  Front Pharmacol       Date:  2017-11-01       Impact factor: 5.810

3.  Improved Cardiac Function and Attenuated Inflammatory Response by Additional Administration of Tirofiban during PCI for ST-Segment Elevation Myocardial Infarction Patients.

Authors:  Jing Zhang; Guomin Ding
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-16       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.